ArticlePharmaceuticals (Basel, Switzerland)2026

Development and Validation of an LC-MS/MS Method for Simultaneous Quantification of Pazopanib, Cabozantinib, Sorafenib, Axitinib, Tivozanib, Sunitinib, and the Metabolites Sorafenib N-Oxide and Desethyl-Sunitinib in Human Plasma.

Eva Greibe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.